Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Volume: 385, Issue: 4, Pages: 320 - 329
Published: Jul 22, 2021
Abstract
Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions.We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other...
Paper Details
Title
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Published Date
Jul 22, 2021
Volume
385
Issue
4
Pages
320 - 329
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.